New screening platform leads to discovery of next-generation prodrugs for type 1 diabetes
With nearly 2 million Americans battling type 1 diabetes, it is no surprise that clinical therapies for the disease are constantly evolving and improving. In type 1 diabetes mellitus, the body's immune system attacks and ...
Dec 16, 2020
0
39